Invesco Pharmaceuticals ETF Rating → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free PJP Stock Alerts $79.67 +0.93 (+1.18%) (As of 05/31/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Invesco Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PJP Aggregate RatingModerate Buy2.73Holdings in PJP have an aggregate rating of Moderate Buy based on 229 analyst ratings issued in the past year covering 21 companies (96.5% of the portfolio).PJP Aggregate Price Target$101.1827.00% UpsideHigh Prediction$125.27Average Prediction$101.18Low Prediction$80.62Holdings in PJP have an aggregate price target of $101.18 and a range of $80.62 to $125.27 covering 21 companies (96.5% of the portfolio).PJP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 PJP Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.46%GERNGeron$3.55+2.3%4 of 5 stars2.80$6.10 71.8%56.31%LLYEli Lilly and Company$820.34+0.6%5 of 5 stars2.84$769.53 -6.2%19Insider Selling6.21%AMGNAmgen$305.85+1.6%5 of 5 stars2.52$305.65 -0.1%21Short Interest ↑5.99%REGNRegeneron Pharmaceuticals$980.16+1.1%4 of 5 stars2.76$989.36 0.9%21Insider SellingHigh Trading Volume5.98%PFEPfizer$28.66+1.6%5 of 5 stars2.40$35.86 25.1%15High Trading Volume5.72%MRKMerck & Co., Inc.$125.54+0.8%4 of 5 stars2.58$131.33 4.6%12Dividend AnnouncementHigh Trading Volume5.39%JNJJohnson & Johnson$146.67+1.0%5 of 5 stars2.38$174.07 18.7%13Analyst ForecastHigh Trading Volume5.20%ABBVAbbVie$161.24+3.2%4 of 5 stars2.79$176.14 9.2%14Short Interest ↑Analyst RevisionHigh Trading Volume5.10%ABTAbbott Laboratories$102.19+0.4%5 of 5 stars2.70$120.64 18.1%10Analyst Forecast5.02%CORTCorcept Therapeutics$30.17-3.3%5 of 5 stars3.00$40.10 32.9%4Analyst ForecastInsider SellingAnalyst Revision4.59%UTHRUnited Therapeutics$275.13+1.7%5 of 5 stars2.90$309.44 12.5%10Insider SellingHigh Trading Volume4.21%LGNDLigand Pharmaceuticals$85.05+1.3%5 of 5 stars3.00$116.33 36.8%3Positive News3.95%ANIPANI Pharmaceuticals$64.90+2.3%5 of 5 stars3.00$81.00 24.8%4Short Interest ↓Positive News3.71%PCRXPacira BioSciences$30.33-0.4%5 of 5 stars3.00$47.40 56.3%10Short Interest ↑Analyst Revision3.65%BIIBBiogen$224.94+2.2%5 of 5 stars2.65$286.50 27.4%26Analyst ForecastShort Interest ↑News Coverage3.44%SUPNSupernus Pharmaceuticals$27.12+2.1%4 of 5 stars3.00$41.00 51.2%1Positive News3.32%PBHPrestige Consumer Healthcare$64.31+2.4%5 of 5 stars2.50$91.25 41.9%4Positive News3.23%GILDGilead Sciences$64.27+0.3%5 of 5 stars2.35$83.69 30.2%17News CoverageGap DownHigh Trading Volume3.07%PRGOPerrigo$27.53+0.8%5 of 5 stars3.00$40.67 47.7%3Analyst UpgradeShort Interest ↑Analyst RevisionNews Coverage3.03%JAZZJazz Pharmaceuticals$105.25-0.2%5 of 5 stars2.85$192.75 83.1%13Analyst UpgradeHigh Trading Volume2.92%AMPHAmphastar Pharmaceuticals$42.33+0.4%5 of 5 stars2.50$66.00 55.9%4Short Interest ↓Positive News This page (NYSEARCA:PJP) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBill Clinton Backing Biden Replacement???The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss Ratings“This will be one of the biggest revolutions ever.” - NVIDIA CEOBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
